X‐linked adrenoleukodystrophy: Therapeutic approaches to distinct phenotypes
- 11 November 2005
- journal article
- review article
- Published by Wiley in Pediatric Transplantation
- Vol. 9 (s7), 55-62
- https://doi.org/10.1111/j.1399-3046.2005.00447.x
Abstract
X-linked adrenoleukodystrophy (X-ALD) in males can present with eight distinct phenotypes, which vary greatly in respect to phenotypic expression, age of onset and rate of progression and therapy. The plasma very long chain fatty acid assay permits precise diagnosis and is already abnormal at birth. The clinical features, molecular biology, pathogenesis, and therapeutic approaches, including the indications for Hematopoietic Stem Cell Transplants (HCT) and dietary therapy are discussed, with emphasis on the asymptomatic, childhood cerebral, and adrenomyeloneuropathy phenotypes. The rationale for neonatal screening and the profound effect that such screening would have on the therapy of X-ALD, including the role of HCT, are discussed.Keywords
This publication has 35 references indexed in Scilit:
- Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screeningThe Journal of Pediatrics, 2005
- Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999Blood, 2004
- Transplantation of boys with X-linked adrenoleukodystrophy with unrelated-donor, partially HLA-mismatched banked umbilical cord bloodTransplantation and Cellular Therapy, 2004
- Quantitative Proton Magnetic Resonance Spectroscopy of Children with Adrenoleukodystrophy Before and After Hematopoietic Stem Cell TransplantationNeuropediatrics, 2003
- Acute Presentation of Childhood AdrenoleukodystrophyNeuropediatrics, 2000
- Exon organisation of the mouse gene encoding the Adrenoleukodystrophy related protein (ALDRP)European Journal of Human Genetics, 1998
- Quantitative Proton Magnetic Resonance Spectroscopy of Childhood AdrenoleukodystrophyNeuropediatrics, 1998
- X-Linked Adrenoleukodystrophy (ALD): A Novel Mutation of the ALD Gene in 6 Members of a Family Presenting with 5 Different PhenotypesBiochemical and Biophysical Research Communications, 1994
- A Two-Year Trial of Oleic and Erucic Acids (“Lorenzo's Oil”) as Treatment for AdrenomyeloneuropathyThe New England Journal of Medicine, 1993
- FATTY ACID ABNORMALITY IN ADRENOLEUKODYSTROPHYJournal of Neurochemistry, 1976